Fezolinetant (Veozah) can cause abdominal pain, diarrhea, insomnia, back pain, hot flushes, and changes in liver blood tests. It is a nonhormonal prescription medicine for moderate to severe menopause-related hot flashes, and its most important safety step is keeping the liver-testing plan tied to your prescription.
Fewer night sweats may make sleep easier for some people, but fezolinetant is approved for hot flashes, not for every cause of insomnia. Your symptom pattern and full medicine list help a clinician decide what belongs in the conversation.
What kind of medicine is fezolinetant?
Fezolinetant is a neurokinin 3 (NK3) receptor antagonist. The FDA approval announcement explains that it blocks an NK3 receptor involved in the brain’s temperature regulation. It is not hormone therapy.
During menopause, the body gradually makes less estrogen and progesterone. The FDA says hot flashes can include sweating, flushing, and chills that last several minutes. This is why a person can feel suddenly overheated, wake sweaty, and then feel cold soon afterward.
What side effects should you put on your list?
The FDA lists abdominal pain, diarrhea, insomnia, back pain, hot flushes, and elevated liver enzymes among the most common side effects. A 2023 review in Health Science Reports also describes these effects from the clinical program.
| What to record | Why it helps | Question for the pharmacist or prescriber |
|---|---|---|
| New stomach symptoms, diarrhea, back pain, sleep changes, or hot flashes | It gives the care team a dated picture instead of a vague memory. | Could this fit the medicine, menopause symptoms, or another medicine on my list? |
| Fatigue, nausea, itching, yellow eyes or skin, light-colored stools, or dark urine | The FDA identifies these as possible signs of liver injury. | What should I do if these symptoms occur, and who should I contact after hours? |
| Liver-test dates and results | Monitoring is part of the medicine’s safety plan. | When are my next tests due, and where will I see the results? |
In September 2024, the FDA warned about rare but serious liver injury after a postmarketing report. The FDA updated the prescribing information to call for testing before treatment, monthly during the first three months, and again at months 6 and 9. The Indian Health Service safety notice repeats that schedule and the symptoms to discuss promptly with the prescriber.
Use a dated symptom log alongside your lab appointments. This side-effect timeline can help you capture what happened, when it started, and what else changed that week.
Who needs an especially careful medication review?
The FDA says Veozah cannot be used with CYP1A2 inhibitors and should not be used by people with known cirrhosis, severe kidney damage, or end-stage kidney disease. CYP1A2 inhibitors are medicines that can raise fezolinetant levels in the body, so this is a medication-list question, not something to guess from memory.
Bring every prescription, over-the-counter medicine, vitamin, and supplement to the visit. Compare the bottle’s brand and generic name with your written list using this medicine-bottle checklist. Ask the pharmacist to identify interaction concerns before a prescription is started or changed.
How does fezolinetant compare with other hot-flash options?
There is no single best option for everyone. The choice depends on the symptom that is disrupting your day or night, your health history, other medicines, preferences, access, and monitoring burden.
| Option | What it is used for | What to compare | Cost question |
|---|---|---|---|
| Hormone therapy | The FDA and clinical literature describe hormone therapy as an established option for menopause-related vasomotor symptoms. | Medical history, route, whether you have a uterus, and the symptoms you want addressed. | Ask the prescriber and pharmacy for the plan-specific price. |
| Fezolinetant | A nonhormonal NK3 receptor antagonist for moderate to severe hot flashes. | Liver-test schedule, kidney and liver history, and the complete medicine list. | The American Academy of Family Physicians listed an estimated lowest GoodRx price of $540 for one month in January 2024; prices as of October 2026 should be confirmed at the pharmacy and with your insurer. |
| Other nonhormonal prescription options | Clinical literature discusses options such as certain SSRIs, gabapentin, and other medicines in selected situations. | Whether the option fits your other conditions and current medicines; sedation and nausea can matter for some choices. | Ask about the exact medicine, generic availability, and coverage. |
| Behavioral and everyday support | Cooling a bedroom, layers, a fan, sleep routines, and stress-management practices may improve comfort for some people. | Whether the main problem is hot flashes, sleep disruption, mood, or another symptom. | Compare the cost and practical fit of the specific program or tool. |
The clinical trials behind FDA approval measured moderate to severe hot flashes. In two 12-week randomized trials, the FDA found fezolinetant effective for this purpose. It has not been directly compared with hormone therapy or every nonhormonal option in the material summarized by the American Academy of Family Physicians, so a side-by-side conversation should focus on your own priorities rather than a universal ranking.
Will it help sleep, weight, vaginal dryness, or every menopause symptom?
Hot flashes and night sweats can interrupt sleep, so reducing them may change how a night feels. But sleep trouble in midlife can have more than one cause. A review in touchREV Endocrinology notes that fezolinetant is most relevant when vasomotor symptoms are the primary concern and may not address concerns such as vaginal dryness, painful sex, urinary symptoms, weight change, or brain fog.
That distinction matters after menopause, too. Menopause means 12 consecutive months without a menstrual period, according to the FDA. Some symptoms change over time, while bone, heart, sleep, mood, and vaginal symptoms may need their own discussion. Feeling better is possible, but it is more useful to name the symptom you want help with than to expect one medicine to cover every change.
What helps you stay healthy through the transition?
The Cleveland Clinic guidance included in menopause education recommends regular weight-bearing movement, nutritious food, limiting alcohol and caffeine when they worsen symptoms, avoiding tobacco, layers, a cooler room, and sleep habits that make winding down easier. These are practical supports, not substitutes for reviewing a new, severe, or disruptive symptom.
Irregular periods can happen during perimenopause. The same guidance says to seek care for very heavy bleeding, large clots, changing pads or tampons every one to two hours, bleeding between periods or after sex, or periods less than 21 days apart. Bring a calendar of bleeding, hot flashes, night sweats, sleep, and current medicines.
Before your next appointment
- Write down how often hot flashes or night sweats happen and how they affect sleep, work, and daily life.
- Record every medicine by brand and generic name, plus supplements and nonprescription products.
- Ask whether any medicine on your list is a CYP1A2 inhibitor.
- Ask what liver testing is needed, where it will be done, and how you will receive results.
- Ask which symptoms the proposed option is meant to address and which need a separate plan.
- Ask your pharmacy and insurer for today’s out-of-pocket cost before filling a prescription.
By the Clear Health Evidence Team
Leave a Reply